Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of Peru.

ABSTRACT:

Background

This study aimed to estimate the economic impact of replacing the current Peruvian primary immunization scheme for infants under 1 year old with an alternative scheme with similar efficacy, based on a hexavalent vaccine.

Methods

A cost-minimization analysis compared the costs associated with vaccine administration, adverse reactions medical treatment, logistical activities, and indirect social costs associated with time spent by parents in both schemes. A budgetary impact analysis assessed the financial impact of the alternative scheme on healthcare budget.

Results

Incorporating the hexavalent vaccine would result in a 15.5% net increase in healthcare budget expenditure ($48,281,706 vs $55,744,653). Vaccination costs would increase by 54.1%, whereas logisti

SUBMITTER: Seinfeld J 

PROVIDER: S-EPMC9109284 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature